•  
  •  
  •  
  •  

2025-12-23 09:51:01

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Aurionpro's Integro Platform to Power Global Lending Modernization for a Top Singaporean Bank
  • Biocon Biologics Secures Full Global Rights to Biosimilar Adalimumab through Expanded FKB In-Licensing Agreement
  • Puravankara announces acquisition of 53-acre land parcel in Bengaluru with GDV of over Rs 4,800 crores
  • Deccan Gold Mines Ltd to invest in a tungsten project in Spain
  • Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial

Keywords Selected:  CaptainPipes

Stock Report

  • Captain Pipes Ltd. announces fund raising of INR 20.6 crores
  • Captain Pipes Ltd Q1 FY2025 profit at Rs. 1.57 crore
  • Captain Pipes Ltd Q3 FY2024 PAT at Rs. 1.01 crore
  • Captain Pipes Ltd to invest Rs. 25 crores for greenfield plant
  • Captain Pipes Ltd to consider setting up of new greenfield manufacturing unit
  • Captain Pipes Ltd receives highest ever Monthly Export Order of USD 360000
  • Captain Pipes Ltd update on expansion project - Completion of New capacity to add 15-20% to sales volume in FY24
  • Captain Pipes Ltd receives approval for migration to main board of BSE
  • Captain Pipes Ltd revises record date for stock split and bonus issue
  • Captain Pipes Ltd Board recommends 2:1 Bonus Issue
  • Captain Pipes Ltd allots 10 lakh warrants

Latest Post

  • Aurionpro's Integro Platform to Power Global Lending Modernization for a Top Singaporean Bank
  • Biocon Biologics Secures Full Global Rights to Biosimilar Adalimumab through Expanded FKB In-Licensing Agreement
  • Puravankara announces acquisition of 53-acre land parcel in Bengaluru with GDV of over Rs 4,800 crores
  • Deccan Gold Mines Ltd to invest in a tungsten project in Spain
  • Glenmark Pharmaceuticals Inc., USA launches Epinephrine Injection USP, 30 mg/30 mL (1 mg/mL) Multiple-Dose Vial


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024